In parallel with Rab5 emerging as a therapeutic target for neurodegenerative disease, p38α has also emerged as a promising therapeutic target for AD and other neurodegenerative disorders [4,19,34,35,36,37,38,39,40,41,42]. Here, RAB5A is linked to neurodegenerative disease.